Related Experiment Video
Updated: Mar 6, 2026

09:42
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
14.1K
Pharmacists and Pediatric Medication Adherence: Bridging the Gap
Hospital Pharmacy
|March 22, 2017
Summary
Pediatric medication nonadherence is a significant issue. Pharmacists can improve adherence through patient-centered counseling and building trust with families.
Area of Science:
- Pediatric Healthcare
- Pharmacology
- Patient Adherence
Background:
- Pediatric medication nonadherence presents a substantial challenge within the US healthcare system.
- Multiple factors influence adherence, including child's age, disease/treatment comprehension, cultural background, socioeconomic status, family dynamics, medication schedules, and taste.
- Effective interventions require a tailored approach, focusing on individual patients and their families.
Purpose of the Study:
- To identify common challenges associated with pediatric medication nonadherence.
- To propose practical solutions for enhancing medication adherence in children.
- To emphasize the role of pharmacists in improving pediatric adherence.
Main Methods:
- This article reviews existing literature and clinical observations regarding pediatric medication nonadherence.
- It synthesizes information on contributing factors and effective intervention strategies.
- The role of pharmacist-led interventions is highlighted.
Main Results:
- Key factors contributing to nonadherence include patient-related, medication-related, and healthcare system-related issues.
- Patient-centered strategies, such as education and motivational interviewing, show promise.
- Pharmacist-led interventions, including counseling and relationship-building, are crucial.
Conclusions:
- Addressing pediatric medication nonadherence requires a multifaceted approach targeting individual and family needs.
- Pharmacists are well-positioned to play a vital role in improving adherence through direct patient care and education.
- Implementing targeted strategies can lead to better health outcomes for pediatric patients.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
342
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
342
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
503
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
503
Pharmacokinetics in Pediatric Patients: Drug Distribution
398
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
398
Drug Dosing: Infants and Children
555
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
555
Pharmacokinetics in Pediatric Patients: Drug Metabolism
303
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
303
Drug Therapy
346
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
346

